AI Spatial Analysis Enhances Understanding of Pancreatic Cancer Recurrence Risk

Recent research from Mayo Clinic demonstrates that artificial intelligence (AI) can enhance risk assessment for pancreatic cancer recurrence by analyzing the spatial organization of cancer cells in routine pathology slides. This approach fundamentally shifts how clinicians evaluate treatment outcomes, particularly regarding pancreatic cancer.

Published in Clinical Cancer Research, the study uncovers that understanding the geometric arrangement of residual cancer may provide deeper insights into recurrence risk, beyond merely quantifying the remaining cancer post-treatment. This is particularly relevant for patients whose tumors show minimal response to chemotherapy pre-surgery.

Patients exhibiting a fragmented and intermixed cancer-stroma pattern tend to experience earlier recurrence. Traditional measures of tumor quantity alone do not effectively differentiate high-risk patients from those at lower risk.

Dr. Ryan Carr, a Mayo Clinic oncologist and the study's senior author, emphasizes the need to go beyond mere quantification of tumor presence. "Current pathology assessments largely tell us how much tumor is left after treatment. We wanted to know whether the geography of that remaining cancer could reveal additional biology about recurrence risk," he states.

Decoding Cancer’s Spatial Patterns

The study encompassed tissue from 203 patients diagnosed with pancreatic ductal adenocarcinoma, all of whom underwent pre-surgical treatment yet exhibited limited pathologic responses. By employing an AI-enabled digital pathology platform combined with techniques from landscape ecology, the research examined how cancer and stroma coexisted on standard hematoxylin and eosin (H&E) slides.

Dr. Carr's broader research connects ecological principles to oncology, focusing on how cancer cells and their surrounding environment influence treatment efficacy and recurrence. By mapping the interactions between cancerous cells and adjacent tissues, the team seeks to understand mechanisms that contribute to resistance against therapies.

Two distinct spatial signatures emerged as predictors of disease-free survival, even after accounting for established clinical factors. High-risk patients saw their adjusted recurrence risk elevated by 71% in one model and over 100% in another, showcasing the efficacy of these spatial analyses compared to traditional metrics.

This method, grounded in existing pathology slides generated during routine diagnostics, could empower clinicians with crucial insights without necessitating additional tissue tests.

Immune Response and Tumor Dynamics

Dr. Carr highlights the potential for AI-driven analysis: "This information is already present in the tissue. AI-enabled analysis gives us a way to measure features that are difficult to capture by eye and potentially add another layer of precision to how we assess risk after surgery."

In addition, the study uncovered that high-risk spatial patterns associated with poor outcomes had fewer immune cells infiltrating the cancer itself, with these cells preferentially clustering around the tumor. This observation points to the significance of the tumor microenvironment in determining treatment resistance and overall disease behavior.

The research complements Mayo Clinic's Precure Research initiative, which aims to leverage data and technology to improve risk predictions and intervene earlier against severe diseases.

As the research progresses, Dr. Carr notes that the ultimate goal is to refine the identification of patients at greatest risk, which could subsequently guide tailored surveillance, therapy, and clinical trial strategies. However, further prospective studies are necessary to validate these findings before they can be integrated into clinical practice.

This study received funding support from several initiatives, including the Gerstner Family Foundation Career Development Award and the Mayo Clinic Center for Clinical and Translational Science. For additional details on authors, disclosures, and funding sources, refer to the study.

About Mayo Clinic
Mayo Clinic  is dedicated to advancing clinical practice, education, and research while providing compassionate care. Explore more on the Mayo Clinic News Network.

Media contact:

• Julie Ferris-Tillman, Ph.D., Mayo Clinic Communications, [email protected]

The post AI Spatial Analysis Enhances Understanding of Pancreatic Cancer Recurrence Risk appeared first on Mayo Clinic News Network.